International Journal of Leading Research Publication

E-ISSN: 2582-8010   •   Impact Factor: 9.56

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Monthly Scholarly International Journal

Call for Paper Volume 7 Issue 7 July 2026 Submit your research before last 3 days of to publish your research paper in the issue of July.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 7 Issue 7
July 2026

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

RNA Therapeutics Beyond mRNA- siRNA, Antisense Oligonucleotide and microRNA as next generation pharmaceutical modalities- formulation, delivery and clinical progress

Author(s) Mr. Shouvik Mondal, Ms. Nilufar Akhtar
Country India
Abstract With highly targeted methods for controlling gene expression and treating a wide range of genetic, metabolic, viral, and cancerous disorders, RNA therapies have become a revolutionary technique in contemporary medicine. The main kinds of RNA (ribonucleic acid) treatments, such as antisense oligonucleotides (ASOs), small interfering RNA (siRNA), and microRNA (miRNA), are thoroughly reviewed in this study along with their methods of action, therapeutic uses, and most recent clinical developments. With a focus on viral and non-viral delivery methods such as lipid nanoparticles, liposomes, polymeric carriers, and viral vectors, this review also covers the formulation and delivery strategies used to enhance the stability, cellular uptake, and target specificity of these compounds. A comprehensive analysis is conducted of current issues, such as nuclease degradation, immune recognition, off-target effects, restricted extrahepatic distribution, and formulation-related hurdles. Furthermore, the expanding clinical value of these technologies is demonstrated by current clinical trials and recent advancements in FDA-approved RNA-based therapies. Promising approaches to circumvent current constraints are also highlighted, such as chemical changes, ligand-targeted delivery systems, formulations based on nanotechnology, and artificial intelligence-assisted therapeutic design. All things considered, RNA therapeutics are a quickly developing discipline with enormous promise to improve precision medicine and offer efficient treatment choices for illnesses that are still challenging to treat with traditional medicines.
Keywords miRNA, siRNA, antisense oligonucleotide (ASO)
Field Chemistry > Pharmacy
Published In Volume 7, Issue 7, July 2026
Published On 2026-07-17
View / Download PDF File

Share this



CrossRef

IJLRP's Crossref DOI prefix is
10.70528/IJLRP

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 7 Isu 6 Cover Page Vol 7 Isu 5 Cover Page Vol 7 Isu 4

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJLRP
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics 		Join as a Reviewer
Editors & Reviewers
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9687-828-838 editor@ijlrp.com